Back in 2011, Sean Duffy had a vision to change healthcare. So, he dropped out of Harvard Business School and Harvard Medical School to found this company, Omada Health, that brought healthcare to people instead of the other way around.

Now valued at over $1 billion, Omada remains an innovative example of how to manage and treat chronic disease. But Sean’s not done yet. In this conversation, we talk about how we’re living in a time where we have the most innovative medicines ever created for metabolic disease. And, the most innovative technology landscape of all time. But the services landscape is absolutely failing, and so we have to look at how to redesign services and the business models that support those services so that we can realize the potential of those technology and treatment innovations.

Sean has always been a visionary, but the way he sees the field of healthcare rivals the best quarterbacks in history. Sean is the Co-founder and CEO of Omada Health, a between-visit care provider that addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. As a former MD/MBA candidate at Harvard, he also holds a BS in neuroscience from Columbia University. He has written extensively about digital health and the future of healthcare in The New England Journal of Medicine, The Wall Street Journal, Forbes, and TechCrunch, among other publications. Prior to Omada, Sean worked at both Google and IDEO.